Remyelinating drug shows potential to improve vision in patients with MS
A team led by a biomedical scientist at the University of California, Riverside, reports a drug an estrogen receptor ligand called indazole chloride (IndCl) has the potential to improve vision in patients with multiple sclerosis, or MS.
The study, performed on mice induced with a model of MS and the first to investigate IndCl s effect on the pathology and function of the complete afferent visual pathway, is published in
Brain Pathology. The afferent visual pathway includes the eyes, optic nerve, and all brain structures responsible for receiving, transmitting, and processing visual information.
Cochlear announces 2021 winners of annual scholarships
The Graeme Clark and Anders Tjellström Scholarship winners recognize exemplary young leaders in the hearing loss community
News provided by
Share this article
Share this article
LONE TREE, Colo., Feb. 3, 2021 /PRNewswire/ Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 19th annual Graeme Clark and the 10th annual Anders Tjellström Scholarships. The scholarships, named after two pioneers of the hearing implant industry, recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and demonstrate high academic achievement. The scholarships are to enable Cochlear recipients to further accomplish their goals through education.
Christopher Rugaber
A customer walks by a Now hiring sign as she enters a Staple s store, Tuesday, Feb. 2, 2021, in Simi Valley, Calif. Hiring has weakened for six straight months. Nearly 10 million jobs remain lost since the coronavirus struck. And this week, the Congressional Budget Office forecast that employment wonât regain its pre-pandemic level until 2024. (AP Photo/Mark J. Terrill) February 03, 2021 - 9:55 AM
WASHINGTON - Hiring has weakened for six straight months. Nearly 10 million jobs remain lost since the coronavirus struck. And this week, the Congressional Budget Office forecast that employment won t regain its pre-pandemic level until 2024.
And yet a hopeful view is gaining steam that as vaccinations reach a critical mass, perhaps around midyear, and the government provides further stimulus, the economy and the job market will strengthen much faster than they did after previous recessions.
U.S. hiring could rebound faster than you might expect
FREE NEWSLETTERS
February 2, 2021
Hiring has weakened for six straight months. Nearly 10 million jobs remain lost since the coronavirus struck. And this week, the Congressional Budget Office forecast that employment won’t regain its pre-pandemic level until 2024.
And yet a hopeful view is gaining steam that, as vaccinations reach a critical mass in the United States, perhaps around midyear, the economy and the job market will strengthen much faster than they did after previous recessions.
“I am not often optimistic,” said Heidi Shierholz, an economist at the liberal Economic Policy Institute. “But I am optimistic now.”
Why U.S. hiring could rebound much faster than expected
A view is gaining steam that as vaccinations increase and the government provides further stimulus, the economy and job market will strengthen more quickly than they did after previous recessions.
By CHRISTOPHER RUGABERAssociated Press
Share
A customer walks by a “Now hiring” sign Tuesday as she enters a Staple’s store in Simi Valley, Calif.
Mark J. Terrill/Associated Press
WASHINGTON Hiring has weakened for six straight months. Nearly 10 million jobs remain lost since the coronavirus struck. And this week, the Congressional Budget Office forecast that employment won’t regain its pre-pandemic level until 2024.